BioAdaptives, Inc.
BDPT
$0.07
$0.01629.63%
OTC PK
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -100.00% | |||
| Gross Profit | -- | 100.00% | |||
| SG&A Expenses | -26.15% | 444.91% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.15% | 176.70% | |||
| Operating Income | 26.15% | -176.70% | |||
| Income Before Tax | 46.99% | -888.83% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 46.99% | -888.83% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 46.99% | -888.83% | |||
| EBIT | 26.15% | -176.70% | |||
| EBITDA | 26.27% | -176.70% | |||
| EPS Basic | 41.87% | -495.24% | |||
| Normalized Basic EPS | 41.88% | -500.00% | |||
| EPS Diluted | 41.87% | -495.24% | |||
| Normalized Diluted EPS | 41.88% | -500.00% | |||
| Average Basic Shares Outstanding | -8.70% | 65.96% | |||
| Average Diluted Shares Outstanding | -8.70% | 65.96% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||